|
|
|
|
|
|
|
| Adenocarcinoma with Squamous Differentiation | ||
| Etiology associated with unopposed estrogen use may be exogenous (non-cycled estrogens) but generally endogenous due to peripheral aromatization of adrenal androgens by adipose in obese women also associated with granulosa cell tumors and other estro- gen producing ovarian tumors as well as polycystic ovary syndrome small group of women with high grade neoplasms lack evidence of hyperestrinism | ||
| Pathogenesis estrogen drives continued proliferation with eventual acquisition of somatic mutations in the absence of progesterone maturation of the endometrium and spiral arteries never occurs, nor does regular menses, | ||
| Epidemiology obese post-menopausal women may also have diabetes and hypertension (classic triad) small group of women with high grade neoplasms lacks these correlates increasing incidence with aging population not picked up on pap smear increasing incidence of squamous differentiation | ||
| General Gross Description fungating, friable, tan mass with irregular infiltration of underlying myometrium Examples: | ||
| General Microscopic Description glands exhibit crowding so that they are "back-to-back" stratified nuclei with mitotic activity cells lose orientation to the lumen nucleoli become prominent, nuclei are vesicular lumenal necrosis if >90% glandular grade 1, 10-90% glandular grade 2, <10% glandular grade 3 presence of squamous cells in >5% considered squamous differentiation benign appearing squamous cells in neoplasms that are grade 1 overtly malignant cells in neoplasms that are grade 3 Examples: | ||
| References Cotran RS, Kumar V, Robbins SL: Robbins Pathologic Basis of Disease. 5th ed. Philadelphia, W.B. Saunders, 1994, pp. 1060-6 This link will directly take you to the relevant new literature Adenocarcinoma with Squamous Differentiation
| Synopsis by: Melinda Sanders M.D. (T84000M85603)[270]
| |
|
|
|
|
|
|